BNTX
BioNTech SE
99.10$
+0.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -85.3% | -45.6% | -182.8% | -2.8% | 4.7% | 78.4% | 140.6% | 7.5% | 15.9% | |
| 17.1% | 17.2% | 31.2% | 8.0% | 0.4% | 0.7% | 4.8% | 10.8% | 13.3% | |
| 9.6% | 6.0% | 27.8% | 6.7% | 0.5% | 0.6% | 1.3% | 3.7% | 3.9% | |
| 49.6% | 6.4% | 27.7% | 5.3% | 6.6% | – | – | – | – | |
| -12.9% | -32.1% | -76.9% | -19.3% | -56.5% | 26.1% | 146.0% | 44.4% | 18.7% | |
| 93.7% | 53.2% | 65.5% | 17.7% | 0.8% | 2.1% | 18.5% | 16.4% | 6.1% | |
| -85.3% | -52.6% | -71.1% | -30.0% | -3.0% | -0.2% | -182.1% | -75.6% | -86.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% | 0.0% | 0.0% | – | |
| 0.0% | 283.5% | 345.6% | 0.0% | 0.0% | -5.7% | -19.3% | 0.0% | 0.0% | |
| -2.7% | 2.7% | 7.3% | 29.4% | -0.4% | -0.3% | -1.1% | -1.7% | -1.8% | |
| -2.7% | 286.2% | 352.9% | 185.5% | 0.5% | -8.2% | -20.4% | -1.7% | -1.8% | |
| -213.6% | 187.6% | 99.1% | 143.3% | 2.5% | 70.4% | -57.9% | -69.1% | -33.8% | |
| -179.1% | -98.8% | -248.3% | -20.5% | 3.9% | 76.3% | 122.2% | -8.9% | 9.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.